Clinical Trial Update: Matched Unrelated Donor Transplant for Metastatic Renal Cell Carcinoma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating matched unrelated donor transplant for metastatic renal cell carcinoma has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Snippet

Sponsor: Center for International Blood and Marrow Transplant Research | Conditions: Metastatic Renal Cell Carcinoma | Phase 2 | Status: TERMINATED